Ovid Release: Company Names M.D., To Scientific Advisory Board Post author:Sam Post published:January 19, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017 Disappointment Hits as Amgen's Repatha Prevents Heart Attacks, But Not Deaths March 16, 2017 Exagen Diagnostics, Inc. Release: Improved Laboratory Testing With EC4d Can Help Physicians Monitor Patients With Lupus June 11, 2017
Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017
Exagen Diagnostics, Inc. Release: Improved Laboratory Testing With EC4d Can Help Physicians Monitor Patients With Lupus June 11, 2017